Cargando…
Therapeutic Potentials of Inhibition of Jumonji C Domain-containing Demethylases in Acute Myeloid Leukemia
OBJECTIVE: Acute myeloid leukemia (AML) is a complex disease affected by both genetic and epigenetic factors. Histone methylation and demethylation are types of epigenetic modification in chromatin remodeling and gene expression. Abnormal expression of histone demethylases is indicated in many types...
Autores principales: | Koca, Duygu, Hastar, Nurcan, Engür, Selin, Kiraz, Yağmur, Ulu, Gizem Tuğçe, Çekdemir, Demet, Baran, Yusuf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057756/ https://www.ncbi.nlm.nih.gov/pubmed/31833715 http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0083 |
Ejemplares similares
-
Jumonji C Demethylases in Cellular Senescence
por: Leon, Kelly E., et al.
Publicado: (2019) -
Cooperation between ETS variant 2 and Jumonji domain-containing 2 histone demethylases
por: Li, Xiaomeng, et al.
Publicado: (2018) -
Systematic discovery of genetic modulation by Jumonji histone demethylases in Drosophila
por: Shalaby, Nevine A., et al.
Publicado: (2017) -
Inhibition of Jumonji demethylases reprograms severe dilated cardiomyopathy and prolongs survival
por: Tran, Tram Anh, et al.
Publicado: (2021) -
Involvement of a Jumonji-C domain-containing histone demethylase in DRM2-mediated maintenance of DNA methylation
por: Deleris, Angelique, et al.
Publicado: (2010)